Ireland
--:--IST
Recruiting Observational

Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry.

NCT05128604 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2022-05-23
Last updated
2025-07-29

Condition(s) studied

Endoscopic Surgical ProcedureSafetyTraining

Investigational drug(s) / intervention(s)

Gastroenterostomy

Gastroenterostomy: Endoscopic ultrasound guided gastroenterostomy

Study summary

This is project of help and support for the introduction of the GASTROENTEROANASTOMOSIS technique guided by ENDOSCOPIC -ULTRASOUND (EUS-GE) in centers in Catalonia, facilitating a teacher training.

The main objective is facilitate a safe introduction of the technique, limiting technical failures, and if necessary, support in rescue techniques.

The goal of this interventional study is to assess the impact of a teaching and on live-support model in the introduction of the gastroenteroanastomosis technique, evaluating its effects in safety and the learning curve.

regarding the results in safety and learning curve of for the introduction \[type of study: observational study or clinical trial\] is to \[learn about, test, compare etc.\] in \[describe participant population/health conditions\]. The main question\[s\] it aims to answer are:

* \[question 1\]
* \[question 2\] Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or more * Gastric outlet obstruction (GOO) caused by passable /unpassable stenosis in the antrum-duodenal region, to malignant or non-malignant conditions * Patient capable of understanding and signing informed consent form * Patient understanding the type of study and complying with the follow-up of complementary tests during the study's duration Exclusion Criteria: * Massive ascites. * Complete stenosis * Failure to sign informed consent form * Patients with intellectual handicap who are unable to understand the nature and possible consequences of the study, unless there is a competent legal representative * Patients unable to adhere to subsequent follow-up requirements * Severe coagulation disorder: INR \> 1.5 not correctible with administration of plasma and/or platelets \< 50,000/mm3

Primary outcome measure(s)

  • Safety introduction of EUS-gastroenterostomy — 12 months
    To determine the safety of this interventional technique, measuring prospectively the adverse events and incidents after after a learning project for helping to introduce this technique.

Trial sites (6)

FacilityCityRegionStatus
Hospital Universitari Germans Trias i Pujol (Can Ruti) Badalona Barcelona, Catalonia Recruiting
Hospital Universitari de Bellvitge L'Hospitalet de Llobregat Barcelona, Catalonia Recruiting
Hospital Universitari Mútua de Terrassa Terrassa Barcelona, Catalonia Recruiting
Hospital de la Santa Creu i Sant Pau Barcelona Barcelona Recruiting
Hospital Del Mar Barcelona Catalonia Recruiting
Hospital Universitari de Girona Doctor Josep Trueta Girona Catalonia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05128604 on ClinicalTrials.gov ↗ ← All trials in Spain